|
This regulatory report is being submitted due to retrospective review through capa 624392.Image review: two videos were provided for review.Both images are of a medtronic bioprosthetic valve at 80%.Neither one was labeled to know which one is the 26 mm valve and which one is the 29 mm.No patient summary was provided for anatomical review.Minimal calcium noted on angiography.Conclusion: it was not possible to confirm the dislodgement on the images provided.Potential factors that can influence dislodgement include tension applied on the delivery catheter system (dcs) during positioning, calcification levels and shape of the native anatomy.Dislodgement events do not typically indicate a failure to meet manufacturing specifications.The instructions for use (ifu) instructs the user that ¿deployment of the bioprosthesis can be attempted 3 times.If the bioprosthesis is recaptured a third time, it must be removed from the patient¿.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|